Weave
Founded Year
2022Stage
Seed VC | AliveTotal Raised
$11.6MLast Raised
$10M | 2 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-147 points in the past 30 days
About Weave
Weave is a company focused on regulatory automation and lifecycle management within the life sciences sector. Its main offerings include an AI-native platform designed to streamline the preparation and submission of regulatory documents, such as Investigational New Drug (IND) applications, by automating content generation, quality review, and data organization. Weave primarily serves the biotech, pharmaceutical, and contract research organizations (CROs) sectors. It was founded in 2022 and is based in New Haven, Connecticut.
Loading...
ESPs containing Weave
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The drug development strategy & compliance platforms market combines AI with regulatory automation and strategic decision-making tools to optimize drug development. These platforms leverage AI for regulatory documentation (including investigational new drug applications), compliance management, and portfolio optimization. Solutions include document automation, data integrity validation, knowledge …
Weave named as Challenger among 9 other companies, including Veeva Systems, IQVIA, and Certara.
Loading...
Research containing Weave
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Weave in 2 CB Insights research briefs, most recently on May 23, 2025.
May 23, 2025
The AI in drug R&D market map
Expert Collections containing Weave
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Weave is included in 2 Expert Collections, including Digital Health.
Digital Health
11,439 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Artificial Intelligence
10,402 items
Latest Weave News
Nov 19, 2024
NEW HAVEN, Conn.--(BUSINESS WIRE)--Weave Bio, an AI-native life sciences platform company, today announced that its AutoIND solution has received the “BioTech AI Innovation of the Year” award in the fourth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products, and services around the globe. Weave’s AutoIND streamlines and accel
Weave Frequently Asked Questions (FAQ)
When was Weave founded?
Weave was founded in 2022.
Where is Weave's headquarters?
Weave's headquarters is located at 467 Ellsworth Avenue, New Haven.
What is Weave's latest funding round?
Weave's latest funding round is Seed VC.
How much did Weave raise?
Weave raised a total of $11.6M.
Who are the investors of Weave?
Investors of Weave include Innovation Endeavors and Magnetic Ventures.
Loading...
Loading...